Leukemia PBMC
Leukemia PBMC samples are collected from clinically confirmed Leukemia donors and cryopreserved. and therapeutic development in Leukemia. These PBMCs are ideal for leukemic cell biology and understanding immune microenvironment.
| Lot # | Condition | Cell Count (M) | Race/Ethnicity | Age | Gender | Country of Collection | Medications | Vials | Price | Action |
|---|---|---|---|---|---|---|---|---|---|---|
| 78956 | Leukemia | 10M | 73 | Male | Ukraine |
Clopidogrel, Rituximab, Cyclophosphamide, Vincristine
|
1 | |||
| 78832 | Leukemia | 10M | 55 | Male | Ukraine |
Losartan
|
1 | |||
| 78833 | Leukemia | 10M | 55 | Male | Ukraine |
Losartan
|
1 | |||
| 78847 | Leukemia | 10M | 58 | Female | Ukraine |
Enalapril
|
1 | |||
| 78848 | Leukemia | 10M | 58 | Female | Ukraine |
Enalapril
|
1 | |||
| 78933 | Leukemia | 10M | 53 | Male | Ukraine |
No medications, Rituximab, Bendamustine, Dexamethasone
|
1 | |||
| 78849 | Leukemia | 10M | 58 | Female | Ukraine |
Enalapril
|
1 | |||
| 78850 | Leukemia | 10M | 58 | Female | Ukraine |
Enalapril
|
1 | |||
| 78934 | Leukemia | 10M | 53 | Male | Ukraine |
No medications, Rituximab, Bendamustine, Dexamethasone
|
1 | |||
| 78935 | Leukemia | 10M | 53 | Male | Ukraine |
No medications, Rituximab, Bendamustine, Dexamethasone
|
1 |
High-Quality PBMCs for Leukemia Research
Leukemia Human PBMC products are sourced from donors clinically diagnosed with leukemia and processed under stringent conditions to support research. These cryopreserved peripheral blood mononuclear cells (PBMCs) enable studies on how leukemia alters normal immune function.
Product Features
- Research Use Only (RUO), cryopreserved PBMCs
- Clinically confirmed leukemia donors
- Available in cell counts ranging from 5 million to 2 billion
- Processed within 24 hours of collection
- Stored using CryoStor® CS10 freezing media
- IRB-approved protocols and electronic informed consent
- Screen LeukoLot™ available prior to bulk orders
De-identified Donor Data
- Verified leukemia diagnosis
- Donor demographics: age, sex assigned at birth, race/ethnicity
- Self-reported allergies and infectious disease history
- Additional leukemia-specific data available upon request
Applications
- Biomarker discovery and validation
- Drug screening and therapeutic development
- Immune pathway analysis in Leukemia pathophysiology
- Transcriptomic and proteomic profiling
Quality and Compliance
- IRB-approved collections and protocols
- 21 CFR Part 11 – compliant e-consent system
- HIPAA-compliant donor data protection
Ordering & Shipping
Leukemia PBMC samples are shipped on dry ice and available in custom aliquots. For international orders or regulatory requirements, please contact learnmore@sanguinebio.com to confirm documentation and compliance needs.
Protocols & Documentation
-
Download
PBMC Isolation from Whole Blood
Standard operating procedure for isolating peripheral blood mononuclear cells from whole blood using density-gradient separation.
-
Download
Immune Cell Isolation
Guidelines for isolating immune cell populations with validated enrichment steps, purity checkpoints, and documentation.
-
Download
Choosing the Right PBMC Configuration
Reference guide comparing PBMC formats, cryopreservation states, and study-fit recommendations for your application.
-
Download
Thawing Cryopreserved PBMC
Validated thawing protocol to recover viable cryopreserved PBMCs while minimizing activation and loss of function.
-
Informed Consent Form (ICF)
Available upon request — confirms donor consent for research use and downstream commercialization.
PBMC
Frequently Asked Questions
1 Answer
YES – All collections are conducted under IRB-approved protocols and electronic informed consent. Sanguine utilizes Advarra and WCG IRB for oversight.
1 Answer
YES – all our products are research use only (RUO).
1 Answer
You can find our full product catalog here.
1 Answer
Storage depends on sample type but often cryopreserved samples stored in liquid nitrogen can be stored for years.
1 Answer
Extensive customization is available. To discuss your project request a quote or email us at learnmore@sanguinebio.com.
1 Answer
Sanguine offers flexible prospective collection services tailored to fit your research. For more information and to request a quote, please see: our prospective biospecimen collection services page.
1 Answer
Timelines depend on condition, sample type, and I/E criteria but we often start collection within 2 weeks of signed agreement.
1 Answer
YES – we have in-stock inventory. You can also email us at learnmore@sanguinebio.com as we continually get new samples in our inventory.
1 Answer
Each sample from a different individual – Unique donor means each sample comes from a different person, ensuring biological diversity in your study.
1 Answer
YES – Unique donors can be specified and guaranteed based on your requirements.
1 Answer
For information about sample quality, please see: Quality and Compliance
1 Answer
YES – “IRB-approved collection protocols” and IRB approval documentation available upon request. Sanguine utilizes two internationally-recognized IRBs (Advarra and WCG IRB) for review and approval.
Ask a Question
Need a custom PBMC cohort?
Our scientific team can scope prospective collections with donor-specific I/E criteria, typically starting within 2 weeks of agreement.